Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4651 AL 4665

Nonpharmacological therapy for the management of neuropsychiatric symptoms of Alzheimer's disease: linking evidence to practice

Staedtler AV, Nunez D.

Worldviews Evid Based Nurs. 2015 Apr;12(2):108-15. doi: 10.1111/wvn.12086. Epub 2015 Mar 21.

Spanish validation of the Person-centered Care Assessment Tool (P-CAT)

Martínez T, Suárez-Álvarez J, Yanguas J, Muñiz J.

Aging Ment Health. 2016;20(5):550-8. doi: 10.1080/13607863.2015.1023768. Epub 2015 Mar 26.

A Comparative Descriptive Study of Characteristics of Early- and Late-Onset Dementia Family Caregivers

Ducharme F, Lachance L, Kergoat MJ, Coulombe R, Antoine P, Pasquier F.

Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):48-56. doi: 10.1177/1533317515578255. Epub 2015 Mar 26.

4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice

Zhang Y, Zou J, Yang J, Yao Z.

Curr Alzheimer Res. 2015;12(4):384-97. doi: 10.2174/1567205012666150325183708.

Regulation of extracellular Zn(2+) homeostasis in the hippocampus as a therapeutic target for Alzheimer's disease

Takeda A, Tamano H.

Expert Opin Ther Targets. 2015;19(8):1051-8. doi: 10.1517/14728222.2015.1029454. Epub 2015 Mar 27.

Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment

Kwon H, Crisostomo AC, Smalls HM, Finke JM.

PLoS One. 2015 Mar 31;10(3):e0120420. doi: 10.1371/journal.pone.0120420. eCollection 2015.

Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials

Gauthier S, Proaño JV, Jia J, Froelich L, Vester JC, Doppler E.

Dement Geriatr Cogn Disord. 2015;39(5-6):332-47. doi: 10.1159/000377672. Epub 2015 Mar 26.

The Human Alzheimer Disease Project: A New Call to Arms

Rosenberg RN, Petersen RC.

JAMA Neurol. 2015 Jun;72(6):626-8. doi: 10.1001/jamaneurol.2015.67.

Tau immunotherapy for Alzheimer's disease

Pedersen JT, Sigurdsson EM.

Trends Mol Med. 2015 Jun;21(6):394-402. doi: 10.1016/j.molmed.2015.03.003. Epub 2015 Apr 3.

Oral Chinese herbal medicine for kidney nourishment in Alzheimer's disease: a systematic review of the effect on MMSE index measures and safety

Zeng LF, Wang NS, Wang Q, Zou YP, Liang ZH, Kong LS, Wu HT, Liao NY, Liang XW, Mo YS.

Complement Ther Med. 2015 Apr;23(2):283-97. doi: 10.1016/j.ctim.2015.01.014. Epub 2015 Feb 13.

Advances in Alzheimer's disease drug development

Rafii MS, Aisen PS.

BMC Med. 2015 Mar 25;13:62. doi: 10.1186/s12916-015-0297-4.

New developments of clinical trial in immunotherapy for Alzheimer's disease

Yang C, Xiao S.

Curr Pharm Biotechnol. 2015;16(6):484-91. doi: 10.2174/138920101606150407112319.

Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials

Jiang J, Jiang H.

Neurol Sci. 2015 Sep;36(9):1633-41. doi: 10.1007/s10072-015-2221-2. Epub 2015 Apr 22.

Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease

Plosker GL.

Drugs. 2015 May;75(8):887-97. doi: 10.1007/s40265-015-0400-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias